RE:RE:RE:RE:Biocloud now getting mentioned in articles I think the issue is that we all thought that -- PG included -- that Biocloud was a great way to deal with the pandemic and would be a boom. Turns out that it will be a post pandemic or "returning to workspaces" kind of product -- for many reasons that are now obvious afterthefact -- which means we arent there yet. But we are getting close.
I suspect the sales will begin to ramp up, easily hitting the goal of 1000 units and probably surpassing it for 2021. I suspect 2022 will be the breakout for sales. If that is so, you wont be able to buy this for $2 much longer.
I can wait. I am an investor and still think I have been blessed to know about this story before most everyone else will, when they will be paying much more to get in on it.
The panic button pressers and penny flippers are just noise for now.